Byers, L. A., Cho, B. C., Cooper, A. J., Chiang, A. C., Han, J., Morgensztern, D., Furqan, M., Dowlati, A., Bar, J., Kim, J., Yokouchi, H., Paz-Ares, L. G., Palenski, T., Rivell, G., Meiman, D., Zhao, Y., Munasinghe, W., Jahchan, N., Chandana, S. R. (2026). ABBV-706 as monotherapy and in combination with budigalimab in patients with relapsed/refractory (R/R) small cell lung cancer (SCLC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8008